Hamel Mouna, Rolain Jean-Marc, Baron Sophie Alexandra
IRD, APHM, MEPHI, Faculté de Médecine et de Pharmacie, Aix Marseille University, CEDEX 05, 13385 Marseille, France.
IHU Méditerranée Infection, CEDEX 05, 13385 Marseille, France.
Microorganisms. 2021 Feb 20;9(2):442. doi: 10.3390/microorganisms9020442.
Since 2015, the discovery of colistin resistance genes has been limited to the characterization of new mobile colistin resistance () gene variants. However, given the complexity of the mechanisms involved, there are many colistin-resistant bacterial strains whose mechanism remains unknown and whose exploitation requires complementary technologies. In this review, through the history of colistin, we underline the methods used over the last decades, both old and recent, to facilitate the discovery of the main colistin resistance mechanisms and how new technological approaches may help to improve the rapid and efficient exploration of new target genes. To accomplish this, a systematic search was carried out via PubMed and Google Scholar on published data concerning polymyxin resistance from 1950 to 2020 using terms most related to colistin. This review first explores the history of the discovery of the mechanisms of action and resistance to colistin, based on the technologies deployed. Then we focus on the most advanced technologies used, such as MALDI-TOF-MS, high throughput sequencing or the genetic toolbox. Finally, we outline promising new approaches, such as omics tools and CRISPR-Cas9, as well as the challenges they face. Much has been achieved since the discovery of polymyxins, through several innovative technologies. Nevertheless, colistin resistance mechanisms remains very complex.
自2015年以来,黏菌素耐药基因的发现仅限于对新型可移动黏菌素耐药()基因变体的特性分析。然而,鉴于所涉及机制的复杂性,仍有许多耐黏菌素细菌菌株的耐药机制不明,对其研究需要借助互补技术。在本综述中,我们通过黏菌素的发展历程,着重介绍了过去几十年中用于促进发现主要黏菌素耐药机制的方法,包括过去的和最近的方法,以及新的技术手段如何有助于加快对新靶基因的快速高效探索。为此,我们通过PubMed和谷歌学术,使用与黏菌素最相关的术语,对1950年至2020年期间发表的有关多粘菌素耐药性的数据进行了系统检索。本综述首先基于所采用的技术,探讨了黏菌素作用机制及耐药性发现的历史。然后我们重点介绍了所使用的最先进技术,如基质辅助激光解吸电离飞行时间质谱(MALDI-TOF-MS)、高通量测序或基因工具箱。最后,我们概述了有前景的新方法,如组学工具和CRISPR-Cas9,以及它们所面临的挑战。自发现多粘菌素以来,通过多种创新技术已取得了很大进展。然而,黏菌素耐药机制仍然非常复杂。